Keywords: qlt, ciba, visudyne, gains, priority, review, phototherapeutics

QLT and CIBA's Visudyne gains priority review

Article | 26 August 1999

Print This

QLT PhotoTherapeutics and CIBA Vision say that the US Food and DrugAdministration has assigned priority review status to the New ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in